{"id":11312,"date":"2025-07-27T01:29:37","date_gmt":"2025-07-26T23:29:37","guid":{"rendered":"https:\/\/valintermed.com\/?p=11312"},"modified":"2025-07-27T01:29:37","modified_gmt":"2025-07-26T23:29:37","slug":"bolezn-greyvsa","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/gray-vsa-disease\/","title":{"rendered":"Graves' disease"},"content":{"rendered":"
<\/div>\n

Graves' disease (or toxic goiter, diffuse toxic goiter) is an autoimmune disorder characterized by hyperfunction of the thyroid gland, which leads to excessive production of thyroid hormones. This condition occurs due to the activation of T-lymphocytes, which produce antibodies to thyroid hormone receptors, thereby stimulating the thyroid gland. The clinical picture of the disease is varied and may include symptoms such as hyperthyroidism, gastrointestinal disorders, tachycardia, weight loss, tremor, changes in the condition of the skin and eyes (exophthalmos). Graves' disease is more common in women, especially at the age of 30-50 years, but can also occur in men. A comprehensive approach to the diagnosis and treatment of this disease requires the participation of several specialists, including endocrinologists, ophthalmologists and, in some cases, surgeons.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n